ALLMedicine™ Lung Adenocarcinoma Center
Research & Reviews 10,423 results
https://doi.org/10.1002/jgm.3341
The Journal of Gene Medicine; Dan W, Shi L et. al.
Apr 12th, 2021 - An increasing body of evidence has revealed that lncRNAs play a significant part in a variety of human cancers; lung adenocarcinoma (LUAD) is included. The expression of PP7080, miR-670-3p and UHRF1BP1 in LUAD cells and tissues was detected by usi...
https://doi.org/10.1016/j.jtho.2021.03.013
Journal of Thoracic Oncology : Official Publication of Th... Odintsov I, Mattar MS et. al.
Apr 11th, 2021 - NRG1 rearrangements produce chimeric ligands that subvert the ERBB pathway to drive tumorigenesis. A better understanding of the signaling networks that mediate transformation by NRG1 fusions is needed to inform effective therapeutic strategies. H...
https://doi.org/10.1016/j.athoracsur.2021.03.065
The Annals of Thoracic Surgery; Fan F, Zhang Y et. al.
Apr 11th, 2021 - Recent studies on the favorable prognosis of ground-glass opacities (GGO) featured lung adenocarcinoma compared with solid nodules were limited to small tumors measuring ≤3.0 cm. This study aimed to investigate whether GGO component could predict ...
https://doi.org/10.18632/aging.202831
Aging Yao B, Wang L et. al.
Apr 11th, 2021 - Interferon-gamma (IFN-γ) plays a complex role in modulating tumor microenvironment during lung adenocarcinoma (LUAD) development. In order to define the role of IFN-γ response genes in LUAD progression, we characterized the gene expression, mutati...
https://doi.org/10.1186/s12957-021-02229-y 10.3322/caac.21262 10.1186/s40659-019-0244-5 10.1038/onc.2011.244 10.18632/oncotarget.12919 10.1038/leu.2015.86 10.1002/jps.23503 10.1007/s12032-014-0162-x 10.1038/ni1337 10.4049/jimmunol.1301315 10.1083/jcb.138.6.1409 10.1182/blood.V91.12.4632 10.1093/intimm/dxs077 10.1172/JCI89281 10.1126/sciimmunol.aay2245 10.1186/s12885-017-3914-0 10.1158/0008-5472.CAN-13-2708 10.1038/onc.2013.370 10.4161/cib.24587 10.1177/1010428317714634 10.3892/or.2017.5948 10.3892/etm_00000025 10.1111/j.1582-4934.2009.00772.x 10.1038/74704 10.1182/blood.V99.3.754 10.1182/blood-2013-02-482570 10.1111/imm.12074 10.1002/1878-0261.12804 10.4049/jimmunol.0803192 10.4049/jimmunol.1801630 10.1002/eji.200636320 10.1016/j.xphs.2020.03.008 10.1111/jphp.13225 10.1177/0271678X19868880 10.3892/or.2019.7162
World Journal of Surgical Oncology; Li YQ, Zheng Z et. al.
Apr 11th, 2021 - Ezrin-radixin-moesin (ERM) have been explored in many cancer processes. Moesin, as its component, has also been found to play an important role in the prognosis of cancer patients, tumor metastasis, drug resistance, and others. Especially in regul...
Clinicaltrials.gov 10,549 results
https://doi.org/10.1002/jgm.3341
The Journal of Gene Medicine; Dan W, Shi L et. al.
Apr 12th, 2021 - An increasing body of evidence has revealed that lncRNAs play a significant part in a variety of human cancers; lung adenocarcinoma (LUAD) is included. The expression of PP7080, miR-670-3p and UHRF1BP1 in LUAD cells and tissues was detected by usi...
https://doi.org/10.1016/j.jtho.2021.03.013
Journal of Thoracic Oncology : Official Publication of Th... Odintsov I, Mattar MS et. al.
Apr 11th, 2021 - NRG1 rearrangements produce chimeric ligands that subvert the ERBB pathway to drive tumorigenesis. A better understanding of the signaling networks that mediate transformation by NRG1 fusions is needed to inform effective therapeutic strategies. H...
https://doi.org/10.1016/j.athoracsur.2021.03.065
The Annals of Thoracic Surgery; Fan F, Zhang Y et. al.
Apr 11th, 2021 - Recent studies on the favorable prognosis of ground-glass opacities (GGO) featured lung adenocarcinoma compared with solid nodules were limited to small tumors measuring ≤3.0 cm. This study aimed to investigate whether GGO component could predict ...
https://doi.org/10.18632/aging.202831
Aging Yao B, Wang L et. al.
Apr 11th, 2021 - Interferon-gamma (IFN-γ) plays a complex role in modulating tumor microenvironment during lung adenocarcinoma (LUAD) development. In order to define the role of IFN-γ response genes in LUAD progression, we characterized the gene expression, mutati...
https://doi.org/10.1186/s12957-021-02229-y 10.3322/caac.21262 10.1186/s40659-019-0244-5 10.1038/onc.2011.244 10.18632/oncotarget.12919 10.1038/leu.2015.86 10.1002/jps.23503 10.1007/s12032-014-0162-x 10.1038/ni1337 10.4049/jimmunol.1301315 10.1083/jcb.138.6.1409 10.1182/blood.V91.12.4632 10.1093/intimm/dxs077 10.1172/JCI89281 10.1126/sciimmunol.aay2245 10.1186/s12885-017-3914-0 10.1158/0008-5472.CAN-13-2708 10.1038/onc.2013.370 10.4161/cib.24587 10.1177/1010428317714634 10.3892/or.2017.5948 10.3892/etm_00000025 10.1111/j.1582-4934.2009.00772.x 10.1038/74704 10.1182/blood.V99.3.754 10.1182/blood-2013-02-482570 10.1111/imm.12074 10.1002/1878-0261.12804 10.4049/jimmunol.0803192 10.4049/jimmunol.1801630 10.1002/eji.200636320 10.1016/j.xphs.2020.03.008 10.1111/jphp.13225 10.1177/0271678X19868880 10.3892/or.2019.7162
World Journal of Surgical Oncology; Li YQ, Zheng Z et. al.
Apr 11th, 2021 - Ezrin-radixin-moesin (ERM) have been explored in many cancer processes. Moesin, as its component, has also been found to play an important role in the prognosis of cancer patients, tumor metastasis, drug resistance, and others. Especially in regul...
News 117 results
https://www.staging.medscape.com/viewarticle/924660
Feb 2nd, 2020 - DUBLIN — An audit found molecular testing has been successfully implemented in the NHS in England with "fantastic" testing rates, but quicker results are needed. The Royal College of Physicians (RCP)'s Spotlight report on molecular testing in adv...
https://www.mdedge.com/fedprac/avaho/article/73840/oncology/assessing-health-related-quality-life-veterans-nonmuscle?channel=263
Oct 3rd, 2019 - Experiment 5 We compared Apple Create ML Image Classifier and Google AutoML Vision in their ability to differentiate between colon adenocarcinoma with mutations in KRAS and colon adenocarcinoma without the mutation in KRAS histopathologic images.
https://www.mdedge.com/hematology-oncology/article/207902/lung-cancer/metformin-tki-combo-improves-pfs-egfr-mutated-lung?channel=39313
Caleb Rans
Sep 10th, 2019 - Combination metformin and epidermal growth factor receptor–tyrosine kinase inhibitor (EGFR-TKI) therapy improved progression-free survival in patients with EGFR-mutated lung adenocarcinoma, according to results from a phase 2 trial. “This is the f.
https://www.medpagetoday.com/hematologyoncology/lungcancer/82015
Sep 6th, 2019 - Adding metformin to standard inhibitors of epidermal growth factor receptor (EGFR) and tyrosine kinase inhibitors (TKIs) significantly improved both progression-free and overall survival in advanced lung adenocarcinoma – with no significant increa...
https://www.mdedge.com/fedprac/avaho/article/207583/lung-cancer/cardiac-tamponade-patient-stage-iv-lung-adenocarcinoma?channel=53
Khan AM, Munir A et. al.
Sep 5th, 2019 - Background: In 2018, a male aged 62 years with a history of squamous cell tonsillar cancer, which was successfully treated by concurrent chemoradiation and selective neck dissection in 2014, was diagnosed with primary right sided lung adenocarcino.